News
Subscribe to the Australian BioCommons monthly newsletter or read previous editions
Invitation to present your structural biology research
The Australian Structural Biology Computing Community is seeking Australian EMCR researchers in structural biology to share their work at a special online meeting.
The Australian Structural Biology Computing Community (ASBC) is a group for anyone who uses computing for structural biology research in Australia. They have a newsletter you can subscribe to, a website full of resources, and they meet online at quarterly meetings.
Their community talk series invites speakers from across the structural biology community to present their work. To wrap up the year, there is a special invitation to Australian EMCR researchers in structural biology to share their work at a special edition of the ASBC community meeting on 4 Nov 2026.
Whether you're in the middle of a project, have completed a project, or published a paper, you are eligible to give a 15 minute talk. Four talks will be selected via an informal and friendly application process. Please send your talk title and a ~250 word abstract to asbc@unsw.edu.au by 31 Aug 2026 to be considered.
BioShell opens a new gateway to national compute for life science researchers
A new ready-to-use virtual environment offers researchers immediate access to a curated set of bioinformatics tools and datasets. BioShell provides a command line interface that is preconfigured for bioinformatics and uses national computer resources, at no cost to researchers.
A new ready-to-use virtual environment offers researchers immediate access to a curated set of bioinformatics tools and datasets. BioShell provides a command line interface that is preconfigured for bioinformatics and uses national computer resources, at no cost to researchers.
By removing the usual ‘setup friction’, BioShell allows researchers to focus on their science, rather than troubleshooting environment configuration or software installations. BioShell offers access to a safe space to experiment on the command line with more power than available on a laptop, avoiding the steep learning curve, complex allocation requests, or specialised architecture required to use high performance computing (HPC) services.
How does BioShell support life science research?
The rapid increase in the volume of available research data in the life sciences necessitates increasingly complex tools to perform effective analysis. BioShell supports researchers with a safe, pre-loaded, secure environment for working in the command-line environment, without the risk of breaking shared infrastructure.
BioShell’s key capabilities include:
Pre-installed workflow engines: ready-to-use software including Singularity, Nextflow, Jupyter Notebook, and RStudio
Built-in support via Shelley: an intuitive command-line agent that allows novice users to search, and run containers from containerised bioinformatics tools with one command
Full administrative control in a safe sandbox: researchers can run workflows and test pipelines with full privileges in an isolated environment.
How did BioShell evolve?
The development of this service, originally called BioImage, is evidence of sustained, national collaboration across Australian research infrastructures. Initially developed on Pawsey Supercomputing Research Centre’s Nimbus Cloud as part of a BioCommons project in 2023, it was further refined by the Sydney Informatics Hub (SIH) at the University of Sydney with regular usage for Australian BioCommons training workshops. Given how useful BioShell proved internally, the SIH team worked with the Australian Research Data Commons (ARDC) Nectar Research Cloud and National Computational Infrastructure (NCI) to ensure the BioShell environment works well with national compute resources.
Start using BioShell now
Researchers across any university or institute can access BioShell to spin up consistent virtual environments on demand. A new application for access to BioShell offers short-term access to national compute resources without the requirement for a full allocation request. For researchers with existing allocations, BioShell is also available via the image catalogue on the ARDC Nectar Research Cloud.
Find out more and request BioShell access
Australian BioCommons partners with the Sydney Informatics Hub, the University of Sydney to manage BioShell, which is underpinned by computational resources provided by the Australian Research Data Commons (ARDC) and National Computational Infrastructure (NCI), building upon original development by the Pawsey Supercomputing Research Centre. This work is enabled by NCRIS via funding from Bioplatforms Australia.
Preview of BioShell’s command line interface, a Jupyter notebook, and RStudio instance.
Scaling bioinformatics and compute access for Australian molecular science research
Seqera has released a new case study featuring Australian BioCommons: Australian BioCommons Standardizes Bioinformatics and Scales Compute Access Nationwide with Seqera.
Seqera has released a new case study featuring Australian BioCommons: Australian BioCommons Standardizes Bioinformatics and Scales Compute Access Nationwide with Seqera. It showcases how BioCommons enables the research community to analyse molecular and biological data at scale through the Australian Nextflow Seqera Service. By leveraging Nextflow and the Seqera Platform, and combining the right bioinformatics expertise and computational infrastructure, the service is driving real-world impact.
“We scaled national access to compute infrastructure. As a result, we now support more than 340 users from more than 40 different Australian organisations.”
— Ziad Al-Bkhetan, Product Manager, Bioinformatics Platforms, Australian BioCommons
The team at Australian BioCommons provides bioinformatics expertise, researcher support, and technical consultations to help researchers effectively utilise bioinformatics software and computational infrastructure for their work. This has standardised bioinformatics analysis nationwide, scaled compute access and capacity beyond institutional limits, and reduced costs by eliminating duplicated infrastructure and set up burdens for individual research groups.
“Seqera Platform has helped us a lot. We've been able to invite our researchers to jump in and see if the platform meets their needs. With the support of the BioCommons, we've had 15 researchers across 7 of our different research groups try it out. It's made launching pipelines easy for researchers who are not familiar with linux systems and command line.
— Julie Iskander, WEHI's Research Computing Platform Engineering team
The success of the Australian Nextflow Seqera Service has earned the team an invitation to present at the upcoming Nextflow Summit. They hope to share the journey of building this nationwide service, highlighting the collaborative effort required to coordinate multiple partners and the transformative impact delivered to researchers. The presentation, “Nextflow Across Australian BioCommons: From Community Training to National Research Infrastructure”, will cover how over the past few years BioCommons has taken a leading role in accelerating Nextflow adoption. Coordinated national activities have spanned live training, reusable training resources, community engagement, and establishing national-scale services for several general-purpose and specialised applications, such as molecular biology and biosecurity. Importantly, it will also describe how these complementary investments have supported the growth of a sustainable national Nextflow ecosystem and the importance of building community capability alongside production research infrastructure.
Explore the Australian Nextflow Seqera Service or read the full case study at Seqera.io.
Australian BioCommons operates the Australian Nextflow Seqera Service in collaboration with Pawsey Supercomputing Research Centre, National Computational Infrastructure (NCI), and Seqera. The Service was established as an output of the Australian BioCommons Bring Your Own Data Expansion Project and is hosted on Amazon Web Services (AWS). These efforts are enabled by NCRIS via funding from Bioplatforms Australia.
Deep learning meets genome annotation: rapid gene prediction tool now available
The deep learning-based genome annotation tool, Tiberius, is now available in Galaxy Australia. After being wrapped and extensively tested, it is freely available for everyone’s use in the Genome Lab.
The deep learning-based genome annotation tool, Tiberius, is now available in Galaxy Australia. After being wrapped and extensively tested, it is freely available for everyone’s use in the Genome Lab.
Tiberius offers gene structure prediction from genomic sequences alone (ab initio). With accuracy that matches tools using extrinsic data, it provides end-to-end prediction of protein-coding genes. Tiberius can be installed and run by individuals, and also parallelised on HPC systems. But now that the wrapper is available in the Galaxy toolshed, it can easily be used by Australian researchers in the Galaxy Australia platform (or installed on any other international Galaxy instance). Tiberius has been trained on organisms in Bacillariophyta, Chlorophyta, Fungi, Insecta, Mammalia, Mesangiospermae, and Vertebrata, and all of those models are available on Galaxy.
During an internship with the Australian Tree of Life Bioinformatics team, University of Queensland PhD candidate, Jane Tung, did much of the initial work to get Tiberius up and running. She benchmarked the performance of three traditional and two machine learning-based eukaryotic genome annotation pipelines using datasets spanning fungi, plants, insects, fish, lizards, amphibians, birds and mammals. Tiberius completed the annotation in a fraction of the time and used fewer resources compared to the traditional pipelines, without a negative effect on quality metrics. Jane will be discussing these findings further in November via the webinar Benchmarking the latest annotation pipelines on Australian reference genomes.
The performance of Tiberius without RNAseq data made this tool the perfect candidate for rapid gene prediction on assemblies produced by the Genome Engine in the Australian BioCommon’s Australian Tree of Life (AToL) project. It has become an essential part of the Genome Engine that will enable rapid, automated assembly, annotation and publication of genomes.
While Tiberius was prioritised for inclusion because it’s an important part of the AToL project, individual researchers can also request the installation of new tools or datasets in Galaxy Australia. For researchers wanting to contribute to the international open source Galaxy community directly, there are supportive guidance videos for DIY tool wrapping. Proactive community members recently took up the challenge, and collaborated with BioCommons to make the first dedicated glycomics tool and workflow available on Galaxy.
Try out Tiberius in the Galaxy Australia Genome Lab
Register for the webinar Benchmarking the latest annotation pipelines on Australian reference genomes
Dr Sarah Beecroft recognised with national award for research enablement
Australian BioCommons is proud to announce that Dr Sarah Beecroft has been awarded the 2026 Early Career eResearch Excellence Prize by AeRO. The prize recognises Sarah’s excellence in research enablement, technical innovation, collaboration, and community leadership.
Australian BioCommons is proud to announce that Dr Sarah Beecroft has been awarded the 2026 Early Career eResearch Excellence Prize by AeRO. The prize recognises Sarah’s excellence in research enablement, technical innovation, collaboration, and community leadership.
After many years of productive collaboration with Sarah, BioCommons now invests directly into Sarah’s role as Lifescience Applications Specialist at the Pawsey Supercomputing Research Centre. BioCommons co-funds this role with Pawsey in recognition that her work to support bioinformatics users through workflow development and optimisation, training, and advocacy is so integral to the success of life science research in Australia.
Sarah’s participation has been key to the delivery of many significant research outcomes, including the recent extraordinary addition of 17 million protein predictions to an international open access database by an Australian researcher, made possible by Sarah’s porting of workflows to enable usage of Setonix's AMD GPUs at Pawsey.
It is wonderful to see that Sarah’s outstanding contributions to the eResearch community have been recognised with one of the AeRO awards. Congratulations Sarah, and keep up the good work!
Sarah regularly shares her expertise via BioCommons training events. You can join her Getting started with GPUs for bioinformatics webinar live in September or catch up on the recording of her recent Using Containers in Nextflow session.
Powering discovery: diverse outputs from ABLeS-enabled research
The Australian BioCommons Leadership Share (ABLeS) has been providing access to infrastructure and computational resources for over 5 years, enhancing the capacity of life scientists to readily harness national infrastructure to accelerate their discoveries. The publications generated by 73 projects involving 471 ABLeS users provide a fascinating insight into the diversity of research requiring large-scale computational power for bioinformatics.
The Australian BioCommons Leadership Share (ABLeS) has been providing access to infrastructure and computational resources for over 5 years, enhancing the capacity of life scientists to readily harness national infrastructure to accelerate their discoveries. Working with Australia’s Tier 1 high-performance computing facilities, Pawsey and NCI, this Australian BioCommons program provides computational resources, specialist expertise, and a shared repository of tools and software, tailored to support life science research communities.
The publications generated by 73 projects involving 471 ABLeS users provide a fascinating insight into the diversity of research requiring large-scale computational power for bioinformatics. Project leads have shared outputs from the first half of the year, offering a snapshot of how ABLeS is supporting research across a diverse range of areas.
As part of the Australian Amphibian and Reptile Genomics initiative (AusARG), Dr Ian Brennan, ANU, leveraged Pawsey compute to document the phylogenomics of native animals:
Prof Benjamin Schwessinger (ANU) from the Plant Pathogen Omics Initiative has used NCI to create outputs that report on stripe rust, the economically significant pathogen of barley and wheat:
Over the years, access to the right national facilities has underpinned the ability of research groups to analyse and process their data. Dr Patricia Agudelo-Romero, and her team The Kids Research Institute, have been utilising their Pawsey resources to great effect, with publications across domains:
Exploring the complexity of the human respiratory virome through an in silico analysis of shotgun metagenomic data retrieved from public repositoriesConservation of gene expression patterns between the amniotic and nasal epithelium at birth
Programming of the respiratory epithelium in utero — insight from the amniotic epithelial methylome
Dr Agudelo-Romero remarked:
“Through ABLeS computing resources, the research I lead at The Kids Research Institute Australia has enabled multi-omics analyses in paediatric respiratory research, including epigenomics, transcriptomics, and metagenomics. This support has facilitated studies ranging from characterising the human respiratory virome to understanding early-life epigenetic programming of the airway, as well as building sustainable bioinformatics capacity through Nextflow and nf-core training.”
Australian BioCommons encourages ABLeS project teams to share publications, software, datasets and other outcomes arising from their allocations so they can be showcased across the community. These examples represent only a small sample of the diverse research communities currently supported through ABLeS. As the BioCommons’ Product Manager, Bioinformatics Platforms, Dr Ziad Al Bkhetan has been thrilled to see the ABLeS service grow:
The publications that are rolling in clearly demonstrate the uplift that happens when ABLeS connects researchers directly to the computational resources they need. Now in its fifth year, ABLeS continues to expand, enabling more projects to take full advantage of the excellent research infrastructure available to Australian researchers.
Learn how ABLeS can support your research
ABLeS is co-funded by Bioplatforms Australia, National Computational Infrastructure and Pawsey Supercomputing Research Centre
Exchanging ideas with European research infrastructures at ELIXIR All Hands
Australian BioCommons join ELIXIR’s All Hands meeting in France this month, an international gathering to share insights and address the challenges of building and sustaining distributed life science data infrastructure.
Key members of the Australian BioCommons team travelled to the ELIXIR All Hands meeting in June to share our insights in building and sustaining distributed life science data infrastructure with European peers. Each year, three staff represent Australia’s activities to more than 500 professionals from over 25 countries. Participants share their successes and seek ways to collaboratively address ongoing challenges facing life science research infrastructures.
ELIXIR, as Europe’s life science research infrastructure, has a mission that is closely aligned with that of Australian BioCommons, and we have maintained a collaboration strategy since 2020. With ongoing face to face interactions a key component of the strategy, Australian BioCommons was well represented at the 2026 All Hands meeting with Dr Melissa Burke, Dr Tiff Nelson, and Jess Holliday attending in Lyon, France.
Immersion in the international life science research infrastructure landscape offered insights across the board, from the technical to the policy level. The opportunity to connect with colleagues in person benefits our normal late-night online meetings across different time zones, making global collaboration possible, more fun and ultimately more successful.
Training Manager, Melissa, reflected, “Collaboration and ‘people infrastructure’ was a standout theme of the meeting. Keynote presentations, symposia and workshops showcased how the networks and collaborations established by ELIXIR are driving cross-border tech solutions like AI factories and federated healthcare data, and influencing European Open Science policy. Investing in people infrastructure by developing research infrastructure staff was noted as key to long term sustainability and strength.”
With the GUARDIANS program entrusted with building national-scale capabilities to support biomedical research using sensitive human omics data, Human Genome Informatics Program Manager, Jess, was keen to hear how international peers are tackling aligned challenges. The opportunities to exchange ideas with the experts gathered from many countries did not disappoint, and Jess returned with nuanced insights into complex national collaborations.
Community Engagement Lead, Tiff, led a workshop to collectively examine current practices and identify opportunities for improving engaging user communities for better services: Building and Operating Fit-for-purpose Services and Platforms through Collaborative User Engagement. It was a wonderful opportunity to highlight the importance of scientific community engagement and showcase the widely-respected process that BioCommons undertakes to build valuable services for life scientists. Tiff was excited to see new tools that have been developed for ELIXIR communities and looks forward to sharing what she’s learnt with Australian researchers.
Our role in building Australia’s research future
To celebrate some of NCRIS’s many successes, the Department of Education has produced a booklet which includes a case study that describes how Australian BioCommons supported the automation of data processing for better border biosecurity.
For more than 20 years, the National Collaborative Research Infrastructure Strategy (NCRIS) has been a cornerstone of Australia’s research success. NCRIS-supported facilities have played a key role in addressing national priorities.
Approximately $5.5 billion has been invested in large, long-term, highly collaborative and national scale projects led by universities, government agencies and private companies to support world-class research. This of course includes investment in people and operations, not just equipment.
NCRIS provides equipment, data, services and expertise to enable world-leading research, development and translation for the benefit of all Australians.
The infrastructure is open to anyone – academics, industry, government and the general public – and is co-funded by state and territory governments, industry, universities and research agencies to minimise costs.
The research infrastructure providers enabled by NCRIS includes Bioplatforms Australia which enhances Australian life science research by investing in state-of-the-art infrastructure and expertise in genomics, proteomics, metabolomics, synthetic biology - and bioinformatics, through Australian BioCommons.
Managed and overseen by the Australian Government, NCRIS has delivered a wide range of national benefits. To celebrate some of its many successes, the Department of Education produced a booklet which included a case study that describes how Australian BioCommons has supported a research group to automate their data analysis for better border biosecurity.
Read Celebrating 20 Years of the National Collaborative Research Infrastructure Strategy (NCRIS).
World-leading Australian science: 17M protein structures added to the AlphaFold Database to accelerate the fight against antimicrobial resistance
Australian researcher, George Bouras, has recently contributed an extraordinary 17 million protein predictions to the AlphaFold Protein Structure Database. This work was possible thanks to the availability of the ColabFold tool on Setonix AMD, the result of collaboration between BioCommons and the Pawsey Supercomputing Research Centre.
Australian researcher, George Bouras, has recently contributed an extraordinary 17 million protein predictions to an international open access database. The availability of the large-scale dataset in the AlphaFold Protein Structure Database will have a transformative impact on the international fight to combat antimicrobial resistance.
As the lead of the AllTheBacteria protein structure prediction project, the Adelaide University bioinformatician and current PhD student completed his world-leading work using resources made available through a BioCommons partnership with Pawsey Supercomputing Research Centre. George’s work became possible only when the right human and compute resources came together. Working closely with BioCommons, Pawsey’s Dr Sarah Beecroft containerised the ColabFold tool for use on Setonix's AMD GPUs. Once ColabFold was ported and stable, George could utilise the massive scale of Pawsey’s Setonix to create the 17 million structural predictions for bacterial proteins.
Source image: AlphaFold prediction of a banna virus spike protein VP4 (AF-0000000365762994-v1). Design credit: Karen Arnott/ EMBL-EBI.
George was honoured to contribute to the AlphaFold Database, one of several high-value datasets for microbial and viral proteins selected from specialist communities. This integration of essential, high-quality datasets from users reinforces the AlphaFold Database’s role as an inclusive, and community-driven resource. The database provides open access to over 200 million protein structure predictions, and the developers,Google DeepMind and EMBL’s European Bioinformatics Institute (EMBL-EBI), are wanting to expand their impact for specialist areas including pandemic preparedness, antimicrobial resistance, neglected tropical diseases and environmental sciences.
“I hope that access to these novel bacterial protein structures derived from high-quality genome assemblies will lead to better understanding of the function of all bacterial proteins.” – George Bouras, lead of the AllTheBacteria
The availability of the ColabFold container for use on Setonix’s AMD GPUs also allowed George to generate more than 3 million phage and viral structures, which are now used for protein structure-informed bacteriophage genome annotation hundreds of thousands of times each day by researchers around the world.
This example shows how close working relationships with both researchers and the Tier-1 HPC infrastructures enables BioCommons to precisely respond to community needs and accelerate Australian science at a scale. Making valuable tools accessible on national platforms is a focus of the BioCommons BioCLI project, and this work paves the way for the creation of a new national protein folding service further streamlining the use of Pawsey computing resources.
A publication about this work is currently under peer review, but in the meantime you can read the release from EBI.
GlyCombo: the first dedicated glycomics workflow on Galaxy
GlyCombo is now live on Galaxy Australia as the platform's first dedicated glycomics software tool. This high-throughput workflow, developed by Protea Glycosciences, offers researchers a streamlined, reproducible way to automate glycan identification from complex mass spectrometry data in just a few clicks.
In a win for the international glycomics community, the first dedicated glycomics and carbohydrate software tool is available on the global Galaxy platform thanks to a group of Australian researchers. GlyCombo, a high-throughput tool for glycan (sugar polymers present in protein samples) identification is now providing glycomics researchers with a streamlined, reproducible way to process their complex mass spectrometry (MS) data within Galaxy Australia. The workflow that performs a conversion of raw files, GlyCombo search, and visualisation of results glycan and polysaccharide compositions from mass spectrometry files has been shared through the publication on the GlyCombo Galaxy workflow on WorkflowHub.
The availability of this tool and workflow is the result of collaboration between the Galaxy Australia team and Protea Glycosciences, an innovative Australian glycosciences company based in Wollongong.
Dr Chris Ashwood and Dr Maia Kelly, Protea Glycosciences
By wrapping their open-source GlyCombo tool for Galaxy, Protea Glycosciences has made state-of-the-art analytical techniques accessible to researchers worldwide with just a few clicks.
How GlyCombo simplifies glycomics analysis
Rapid identification of glycans present in MS samples is a cornerstone of glycomics research and is integral to robust glycomics analysis pipelines, yet glycomics research is often limited by a lack of throughput and reproducible data analysis to enable subsequent structural elucidation. Protea Glycosciences was established in 2023 to address this gap, bringing a structure-oriented approach.
While traditional web-based tools utilise point-and-click interactions, GlyCombo enables researchers to rapidly process large-scale, complex MS datasets with greater efficiency and reproducibility. Through text-based commands, glycomics researchers can automate the assignment of monosaccharide combinations, handle multiple adduct searches, and anticipate off-by-one errors, while simultaneously maintaining detailed records of their analytical workflows.
The Galaxy GlyCombo workflow successfully monitored the glycomic consequences of biotransformation, detecting the drastic compositional shifts resulting from sialidase treatment directly within a fully reproducible, browser-based workflow.
Bringing the tool to Galaxy Australia
Protea Glycosciences have wrapped their open source tool for the platform, and the Galaxy Australia team have provided technical support to enable this easy access to the software. The integration of GlyCombo onto Galaxy Australia is a prime example of how national research infrastructure supports the Australian life sciences ecosystem, and how BioCommons and Galaxy Australia support industry-based Research and Development. Hundreds of researchers from Australian small-to-medium enterprises (SMEs) and startups use these subsidised services and the generous computational and working data storage quotas to accelerate their work.
“We built GlyCombo as an open-source tool to solve an analytical challenge, but software is only useful if people can run it. Galaxy makes complex workflows reproducible and accessible without local infrastructure or programming expertise. Partnering with Galaxy Australia was a direct path to putting rigorously tested glycomics workflows in front of researchers who need it and lowers the barrier to entry for the broader glycomics community.” - Dr Chris Ashwood, Director, Protea Glycosciences.
Learn more